Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Buy

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Neutral

Analyst Rating

Strong Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Humana Inc. (HUM)

Hospital & Medical Service Plans

http://www.humana.com

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

500 W MAIN ST
LOUISVILLE, KY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/18/1971

Market Cap

42,265,918,080

Shares Outstanding

123,110,000

Weighted SO

123,110,720

Total Employees

N/A

Upcoming Earnings

07/31/2024

Beta

0.5150

Last Div

3.5400

Range

298.61-530.54

Chg

-6.1900

Avg Vol

1280666

Mkt Cap

42265918080

Exch

NYSE

Country

US

Phone

502 580 1000

DCF Diff

-796.5776

DCF

1244.3376

Div Yield

0.0101

P/S

0.3773

EV Multiple

21.7045

P/FV

2.5362

Div Yield %

1.0084

P/E

24.7113

PEG

1.8682

Payout

0.2548

Current Ratio

0.2780

Quick Ratio

2.1450

Cash Ratio

0.2780

DSO

13.3247

DIO

-1014.9022

Op Cycle

-1001.5774

DPO

179.2862

CCC

-1180.8636

Gross Margin

0.8814

Op Margin

0.0276

Pretax Margin

0.0218

Net Margin

0.0153

Eff Tax Rate

0.2686

ROA

0.0342

ROE

0.1037

ROCE

0.1019

NI/EBT

0.7015

EBT/EBIT

0.7896

EBIT/Rev

0.0276

Debt Ratio

0.2574

D/E

0.7735

LT Debt/Cap

0.4133

Total Debt/Cap

0.4361

Int Coverage

5.2624

CF/Debt

-0.3293

Equity Multi

3.0048

Rec Turnover

27.3927

Pay Turnover

2.0359

Inv Turnover

-0.3596

FA Turnover

39.7150

Asset Turnover

2.2366

OCF/Share

-35.2526

FCF/Share

-41.9611

Cash/Share

190.3358

OCF/Sales

-0.0379

FCF/OCF

1.1903

CF Coverage

-0.3293

ST Coverage

-3.6954

CapEx Coverage

-5.2550

Div&CapEx Cov

-3.4132

P/BV

2.5362

P/B

2.5362

P/S

0.3773

P/E

24.7113

P/FCF

-8.3629

P/OCF

-9.9578

P/CF

-9.9578

PEG

1.8682

P/S

0.3773

EV Multiple

21.7045

P/FV

2.5362

DPS

3.5400

Latest Headlines (EST)

GlobeNewswire Inc. Jun 19, 20:38 Expanding Access in California: SmartVascular Dx™ Test Now Available Through Major Health Plans GlobeNewswire Inc. Jun 06, 22:13 INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Humana Inc. (NYSE: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm Investing.com May 26, 21:09 Is UnitedHealth the Boeing of Healthcare? Why It May Be Too Big to Break GlobeNewswire Inc. Jan 11, 21:14 HUMA DEADLINE: ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA GlobeNewswire Inc. Jan 05, 18:23 ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - HUMA Benzinga Jan 02, 21:06 Humacyte, Inc. (HUMA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit GlobeNewswire Inc. Dec 30, 23:54 ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA GlobeNewswire Inc. Dec 24, 20:58 HUMA Lead Plaintiff Deadline Approaching – Contact Robbins LLP for Information About the Class Action Against Humacyte, Inc. GlobeNewswire Inc. Dec 24, 03:55 ROSEN, A LONGSTANDING FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA GlobeNewswire Inc. Dec 21, 03:58 ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA GlobeNewswire Inc. Dec 20, 03:47 Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma GlobeNewswire Inc. Dec 20, 02:00 HUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the Firm GlobeNewswire Inc. Dec 20, 00:23 DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte GlobeNewswire Inc. Dec 10, 23:49 DEADLINE ALERT for PACS, HAS, ASML, HUMA: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire Inc. Nov 30, 18:49 ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA GlobeNewswire Inc. Nov 30, 18:49 ????????? ROSEN ?? Humacyte, Inc. ????? HUMA ????????????????????? GlobeNewswire Inc. Nov 28, 00:15 ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HUMA GlobeNewswire Inc. Nov 26, 22:44 SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte GlobeNewswire Inc. Nov 26, 02:00 HUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the Firm GlobeNewswire Inc. Nov 24, 05:23 Humacyte, Inc. Shareholder Alert: Robbins LLP Reminds Investors of the HUMA Securities Class Action

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.88 06/28/2024 04/18/2024 06/28/2024 07/26/2024
0.88 03/27/2024 02/15/2024 03/29/2024 04/26/2024
0.88 12/28/2023 10/31/2023 12/29/2023 01/26/2024
0.88 09/28/2023 08/17/2023 09/29/2023 10/27/2023
0.88 06/29/2023 04/20/2023 06/30/2023 07/28/2023
0.88 03/30/2023 02/16/2023 03/31/2023 04/28/2023
0.79 12/29/2022 10/27/2022 12/30/2022 01/27/2023
0.79 09/29/2022 08/18/2022 09/30/2022 10/28/2022
0.79 06/29/2022 04/21/2022 06/30/2022 07/29/2022
0.79 03/30/2022 02/17/2022 03/31/2022 04/29/2022
0.70 12/30/2021 10/28/2021 12/31/2021 01/28/2022
0.70 09/29/2021 08/19/2021 09/30/2021 10/29/2021
0.70 06/29/2021 04/22/2021 06/30/2021 07/30/2021
0.70 03/30/2021 02/18/2021 03/31/2021 04/30/2021
0.62 12/30/2020 11/03/2020 12/31/2020 01/29/2021
0.62 09/29/2020 08/20/2020 09/30/2020 10/30/2020
0.62 06/29/2020 04/23/2020 06/30/2020 07/31/2020
0.62 03/30/2020 02/20/2020 03/31/2020 04/24/2020
0.55 12/30/2019 10/24/2019 12/31/2019 01/31/2020
0.55 09/27/2019 08/22/2019 09/30/2019 10/25/2019
0.55 06/27/2019 04/18/2019 06/28/2019 07/26/2019
0.55 03/28/2019 02/07/2019 03/29/2019 04/26/2019
0.50 12/28/2018 11/02/2018 12/31/2018 01/25/2019
0.50 09/27/2018 08/16/2018 09/28/2018 10/26/2018
0.50 06/28/2018 04/19/2018 06/29/2018 07/27/2018
0.50 03/28/2018 02/07/2018 03/30/2018 04/27/2018
0.40 12/28/2017 11/02/2017 12/29/2017 01/26/2018
0.40 09/28/2017 08/16/2017 09/29/2017 10/27/2017
0.40 06/28/2017 04/20/2017 06/30/2017 07/31/2017
0.40 03/29/2017 02/15/2017 03/31/2017 04/28/2017
0.29 01/10/2017 10/27/2016 01/12/2017 01/27/2017
0.29 10/11/2016 08/26/2016 10/13/2016 10/28/2016
0.29 06/28/2016 04/22/2016 06/30/2016 07/29/2016
0.29 03/29/2016 02/19/2016 03/31/2016 04/29/2016
0.29 12/28/2015 10/30/2015 12/30/2015 01/29/2016
0.29 09/28/2015 08/28/2015 09/30/2015 10/30/2015
0.29 06/26/2015 04/17/2015 06/30/2015 07/31/2015
0.28 03/27/2015 02/19/2015 03/31/2015 04/24/2015
0.28 12/29/2014 10/31/2014 12/31/2014 01/30/2015
0.28 09/26/2014 08/28/2014 09/30/2014 10/31/2014
0.28 06/26/2014 04/30/2014 06/30/2014 07/25/2014
0.27 03/27/2014 02/19/2014 03/31/2014 04/25/2014
0.27 12/27/2013 10/31/2013 12/31/2013 01/31/2014
0.27 09/26/2013 08/23/2013 09/30/2013 10/25/2013
0.27 06/26/2013 04/25/2013 06/28/2013 07/26/2013
0.26 03/26/2013 02/27/2013 03/28/2013 04/26/2013
0.26 12/27/2012 10/19/2012 12/31/2012 01/25/2013
0.26 09/26/2012 08/24/2012 09/28/2012 10/26/2012
0.26 06/27/2012 05/01/2012 06/29/2012 07/27/2012
0.25 03/28/2012 02/27/2012 03/30/2012 04/27/2012
0.25 12/28/2011 10/25/2011 12/30/2011 01/31/2012
0.25 09/28/2011 08/22/2011 09/30/2011 10/28/2011
0.25 06/28/2011 04/27/2011 06/30/2011 07/28/2011
13.88 03/08/1993 11/30/-0001 11/30/-0001 11/30/-0001
0.22 12/28/1992 11/30/-0001 01/04/1993 02/01/1993
0.22 09/25/1992 11/30/-0001 10/01/1992 11/02/1992
0.22 06/25/1992 11/30/-0001 07/01/1992 08/03/1992
0.22 03/26/1992 11/30/-0001 04/01/1992 05/01/1992
0.22 12/26/1991 11/30/-0001 01/02/1992 02/03/1992
0.22 09/25/1991 11/30/-0001 10/01/1991 11/01/1991
0.34 06/25/1991 11/30/-0001 07/01/1991 08/01/1991
0.30 03/25/1991 11/30/-0001 04/01/1991 05/01/1991
0.30 12/26/1990 11/30/-0001 11/30/-0001 11/30/-0001
0.30 09/25/1990 09/17/1990 10/01/1990 11/01/1990
0.30 06/26/1990 05/11/1990 07/02/1990 08/01/1990
0.26 03/27/1990 03/09/1990 04/02/1990 05/01/1990
0.26 12/26/1989 11/03/1989 01/02/1990 02/01/1990
0.26 09/27/1989 09/18/1989 10/03/1989 11/01/1989
0.26 06/27/1989 05/12/1989 07/03/1989 08/01/1989
0.23 03/28/1989 03/06/1989 04/03/1989 05/01/1989
0.23 12/23/1988 11/07/1988 01/02/1989 02/01/1989
0.23 09/27/1988 09/26/1988 10/03/1988 11/01/1988
0.23 06/27/1988 05/13/1988 07/01/1988 08/01/1988
0.20 03/25/1988 03/04/1988 03/31/1988 05/02/1988
0.20 12/28/1987 11/06/1987 01/04/1988 02/01/1988
0.20 09/28/1987 09/14/1987 10/02/1987 11/02/1987
0.20 06/25/1987 05/08/1987 07/01/1987 08/01/1987
0.19 03/27/1987 03/09/1987 04/02/1987 05/01/1987
0.19 12/26/1986 11/10/1986 01/02/1987 02/02/1987
0.19 09/29/1986 11/30/-0001 11/30/-0001 11/30/-0001
0.19 06/27/1986 11/30/-0001 11/30/-0001 11/30/-0001
0.19 03/26/1986 11/30/-0001 11/30/-0001 11/30/-0001
0.19 12/27/1985 11/30/-0001 11/30/-0001 11/30/-0001
0.17 09/30/1985 11/30/-0001 11/30/-0001 11/30/-0001
0.17 06/27/1985 11/30/-0001 11/30/-0001 11/30/-0001
0.17 03/27/1985 11/30/-0001 11/30/-0001 11/30/-0001
0.17 12/28/1984 11/30/-0001 11/30/-0001 11/30/-0001
0.15 09/27/1984 11/30/-0001 11/30/-0001 11/30/-0001
0.15 06/27/1984 11/30/-0001 11/30/-0001 11/30/-0001
0.15 03/27/1984 11/30/-0001 11/30/-0001 11/30/-0001
0.18 12/28/1983 11/30/-0001 11/30/-0001 11/30/-0001
0.15 09/27/1983 11/30/-0001 11/30/-0001 11/30/-0001
0.15 06/29/1983 11/30/-0001 11/30/-0001 11/30/-0001
0.15 03/28/1983 11/30/-0001 11/30/-0001 11/30/-0001
0.20 12/29/1982 11/30/-0001 11/30/-0001 11/30/-0001
0.15 09/28/1982 11/30/-0001 11/30/-0001 11/30/-0001
0.15 06/29/1982 11/30/-0001 11/30/-0001 11/30/-0001
0.15 03/29/1982 11/30/-0001 11/30/-0001 11/30/-0001